http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2475762-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8b7983e068f3121315cf13aaa00ab0c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-126 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 |
filingDate | 2004-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_701973d05ab1e6933084c9b0d9389dd0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_809b98436e9cac0cbc5e21b2a0a62869 |
publicationDate | 2006-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2475762-A1 |
titleOfInvention | Dose dependent elimination of ha and cell receptor stimulation |
abstract | The invention provides a method to alter elimination kinetics of hyaluronic acid (HA) in a patient is disclosed. Administration of HA to a patient, followed by at least one subsequent administration results in an alteration of the ability of the patient to eliminate HA. Also disclosed is a method for upregulating, and/or increasing the affinity of cellular HA receptors. Also disclosed are methods for increasing the ability of cells to bind HA improved imagine of cells and tissues, determination of the existence of disease in a patient. |
priorityDate | 2004-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.